Literature DB >> 21349780

Multidimensionality of microarrays: statistical challenges and (im)possible solutions.

Stefan Michiels1, Andrew Kramar, Serge Koscielny.   

Abstract

A typical array experiment yields at least tens of thousands of measurements on often not more than a hundred patients, a situation often denoted as the curse of dimensionality. With a focus on prognostic multi-biomarker scores derived from microarrays, we highlight the multidimensionality of the problem and the issues in the multidimensionality of the data. We go over several statistical challenges raised by this curse occurring in each step of microarray analysis on patient data, from the hypothesis and the experimental design to the analysis methods, interpretation of results and clinical utility. Different analytical tools and solutions to answer these challenges are provided and discussed.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349780      PMCID: PMC5528286          DOI: 10.1016/j.molonc.2011.01.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  49 in total

1.  False discovery rate, sensitivity and sample size for microarray studies.

Authors:  Yudi Pawitan; Stefan Michiels; Serge Koscielny; Arief Gusnanto; Alexander Ploner
Journal:  Bioinformatics       Date:  2005-04-19       Impact factor: 6.937

2.  Microarrays: retracing steps.

Authors:  Kevin R Coombes; Jing Wang; Keith A Baggerly
Journal:  Nat Med       Date:  2007-11       Impact factor: 53.440

Review 3.  How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.

Authors:  David F Ransohoff
Journal:  J Clin Epidemiol       Date:  2007-09-24       Impact factor: 6.437

4.  Why most gene expression signatures of tumors have not been useful in the clinic.

Authors:  Serge Koscielny
Journal:  Sci Transl Med       Date:  2010-01-13       Impact factor: 17.956

5.  Reporting recommendations for tumor marker prognostic studies (REMARK).

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

6.  Making informed choices about microarray data analysis.

Authors:  Mark Reimers
Journal:  PLoS Comput Biol       Date:  2010-05-27       Impact factor: 4.475

Review 7.  Critical review of microarray-based prognostic tests and trials in breast cancer.

Authors:  Serge Koscielny
Journal:  Curr Opin Obstet Gynecol       Date:  2008-02       Impact factor: 1.927

Review 8.  Systematic review: gene expression profiling assays in early-stage breast cancer.

Authors:  Luigi Marchionni; Renee F Wilson; Antonio C Wolff; Spyridon Marinopoulos; Giovanni Parmigiani; Eric B Bass; Steven N Goodman
Journal:  Ann Intern Med       Date:  2008-02-04       Impact factor: 25.391

9.  Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

Review 10.  Interpretation of microarray data in cancer.

Authors:  S Michiels; S Koscielny; C Hill
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

View more
  5 in total

1.  Distance-based classifiers as potential diagnostic and prediction tools for human diseases.

Authors:  Boris Veytsman; Lei Wang; Tiange Cui; Sergey Bruskin; Ancha Baranova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

Review 2.  Multidimensionality of microarrays: statistical challenges and (im)possible solutions.

Authors:  Stefan Michiels; Andrew Kramar; Serge Koscielny
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

Review 3.  Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.

Authors:  S Michiels; N Ternès; F Rotolo
Journal:  Ann Oncol       Date:  2016-09-15       Impact factor: 32.976

4.  A computational framework for complex disease stratification from multiple large-scale datasets.

Authors:  Bertrand De Meulder; Diane Lefaudeux; Aruna T Bansal; Alexander Mazein; Amphun Chaiboonchoe; Hassan Ahmed; Irina Balaur; Mansoor Saqi; Johann Pellet; Stéphane Ballereau; Nathanaël Lemonnier; Kai Sun; Ioannis Pandis; Xian Yang; Manohara Batuwitage; Kosmas Kretsos; Jonathan van Eyll; Alun Bedding; Timothy Davison; Paul Dodson; Christopher Larminie; Anthony Postle; Julie Corfield; Ratko Djukanovic; Kian Fan Chung; Ian M Adcock; Yi-Ke Guo; Peter J Sterk; Alexander Manta; Anthony Rowe; Frédéric Baribaud; Charles Auffray
Journal:  BMC Syst Biol       Date:  2018-05-29

5.  Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.

Authors:  S B Amin; W-K Yip; S Minvielle; A Broyl; Y Li; B Hanlon; D Swanson; P K Shah; P Moreau; B van der Holt; M van Duin; F Magrangeas; P Pieter Sonneveld; K C Anderson; C Li; H Avet-Loiseau; N C Munshi
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.